The Effect of Lactobacillus plantarum 299v on the Incidence of Clostridium difficile Infection in High Risk Patients Treated with Antibiotics

Recurrent Clostridium difficile infection is associated with increased mortality

(2015) M.A. Olsen et al.   CLINICAL MICROBIOLOGY AND INFECTION

European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection

(2013) S.B. Debast et al.   CLINICAL MICROBIOLOGY AND INFECTION

A probiotic trial: tipping the balance of evidence?

(2013) Nick Daneman   LANCET

Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial

(2013) Stephen J Allen et al.   LANCET

Anchorless surface associated glycolytic enzymes from Lactobacillus plantarum 299v bind to epithelial cells and extracellular matrix proteins

(2013) Jacob Glenting et al.   MICROBIOLOGICAL RESEARCH

Lactobacillus plantarum 299v reduces colonisation of Clostridium difficile in critically ill patients treated with antibiotics

(2010) B. KLARIN et al.   ACTA ANAESTHESIOLOGICA SCANDINAVICA

Intake of Lactobacillus plantarum Reduces Certain Gastrointestinal Symptoms During Treatment With Antibiotics

(2010) Elisabet Lönnermark et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

The growing incidence and severity ofClostridium difficileinfection in inpatient and outpatient settings

(2010) Sahil Khanna et al.   Expert Review of Gastroenterology & Hepatology

Clostridium difficilein Solid Organ Transplant Recipients

(2009) E. R. Dubberke et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Biodiversity of mannose-specific adhesion in Lactobacillus plantarum revisited: strain-specific domain composition of the mannose-adhesin

(2009) G. Gross et al.   Beneficial Microbes